Tnfrsf26 inhibitors are a class of chemical compounds that specifically target the Tnfrsf26 protein, a member of the tumor necrosis factor receptor superfamily involved in regulating various cellular processes. These inhibitors primarily work by binding to the active or binding sites of the Tnfrsf26 protein, preventing its interaction with natural ligands or other associated molecules. By blocking these key interactions, Tnfrsf26 inhibitors disrupt the protein's ability to carry out its normal function in cellular signaling pathways. In some instances, these inhibitors may also act through allosteric mechanisms, binding to regions of the protein distant from the active site. This allosteric binding induces conformational changes in the Tnfrsf26 protein, reducing or entirely inhibiting its activity. The inhibitors form stable complexes with the Tnfrsf26 protein through non-covalent interactions, such as hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic bonds, ensuring effective inhibition of the protein's function.
The structural design of Tnfrsf26 inhibitors is highly diverse, allowing them to interact with the protein in a specific and effective manner. These inhibitors often feature functional groups such as hydroxyl, amine, or carboxyl groups, which enable them to form hydrogen bonds and ionic interactions with the amino acid residues in the protein's binding pockets. Aromatic rings and heterocyclic backbones are common structural motifs in Tnfrsf26 inhibitors, facilitating hydrophobic interactions with non-polar regions of the protein and enhancing binding stability. Additionally, the physicochemical properties of these inhibitors, such as molecular weight, solubility, polarity, and lipophilicity, are carefully optimized to ensure that the inhibitors can maintain their structural integrity and activity in different biological environments. By balancing hydrophobic and hydrophilic regions within their molecular structures, Tnfrsf26 inhibitors achieve strong, selective binding to both polar and non-polar areas of the protein, ensuring effective modulation of Tnfrsf26 activity across various conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates the TNF-α pathway, potentially affecting the signaling cascade related to TNFRSF26. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Inhibits TNF-α production, possibly impacting TNFRSF26 signaling indirectly through modulation of the TNF pathway. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
A JAK inhibitor that could modulate signaling pathways downstream of TNFRSF26, affecting processes like inflammation and immune response. | ||||||
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
Inhibits p38 MAPK, a kinase involved in the downstream signaling of many TNF receptors, potentially affecting signaling pathways associated with TNFRSF26. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may be involved in signaling pathways downstream of TNFRSF26, particularly in processes related to apoptosis and inflammation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Specifically inhibits p38 MAPK, which could indirectly influence TNFRSF26 signaling by modulating inflammatory and stress response pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is involved in the MAPK/ERK pathway, potentially affecting downstream signaling of TNFRSF26 in cell survival and proliferation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound that can modulate NF-κB activity, potentially influencing signaling pathways related to TNFRSF26. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenolic compound that can inhibit NF-κB signaling, possibly affecting TNFRSF26 activity indirectly by modulating inflammatory responses and cell survival. | ||||||